In vitro activities of meropenem and other antimicrobial agents against British meningococcal isolates

Chemotherapy

Volumn 45, Issue 4, 1999, Pages 253-257

  Abadi, Fariborz J R ^a   Yakubu, Davis E ^a   Pennington, T Hugh ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Meningitis; Meningococcal strains; Meropenem; Prophylaxis

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; MEROPENEM; PENICILLIN G; RIFAMPICIN; SULFADIAZINE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; GREAT BRITAIN; MICROBIAL SENSITIVITY TESTS; NEISSERIA MENINGITIDIS; THIENAMYCINS;

EID: 0033009889     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007194     Document Type: Article

References (15)

1. Sutcliffe EM, Jones DM, El-Sheikh S, Pervical A: Penicillin insensitive meningococci in the UK. Lancet 1988;1:657-658.
2. Abadi FJR, Yakubu DE, Pennington TH: Antimicrobial susceptibility of penicillin-sensitive and penicillin-resistant meningococci. J Antimicrob Chemother 1995;35:687-690.
3. Carter PE, Abadi FJR, Yakubu DE, Pennington TH: Molecular characterisation of rifampicin-resistant Neisseria meningitidis. Antimicrob Agents Chemother 1994;38:1256-1261.
4. Yakubu DE, Abadi FJR, Pennington TH: Molecular epidemiology of recent UK isolates of Neisseria meningitidis serogroup C. Epidemiol Infect 1994;113:53-65.
5. Mason PR, Gwanzura L, Latif AS, Marowa E, Ray S, Katzenstein DA: Antimicrobial resistance in gonococci isolated from patients and from commercial sex workers in Harare, Zimbabwe. Int J Antimicrob Agents 1997;9:175-179.
6. Cuevas LE, Kazembe P, Mughogho GK, Tillotson GS, Hart CA: Eradication of nasopharyngeal carriage of Neisseria meningitidis in children and adults in rural Africa: A comparison of ciprofloxacin and rifampicin. J Infect Dis 1995;171:728-731.
7. Glauser MP: Monotherapy for the neutropenic patients: A realistic goal? Curr Opin Infect Dis 1994;7 (suppl 1):S11-S16.
8. Yakubu DE, Pennington TH: Epidemiological evaluation of Neisseria meningitidis serogroup B by pulsed-field gel electrophoresis. FEMS Immunol Med Microbiol 1995;10: 185-190.
9. Abadi FJR, Carter PE, Cash P, Pennington TH: Rifampicin resistance in Neisseria meningitidis due to alteration in membrane permeability. Antimicrob Agents Chemother 1996;40:646-651.
10. Strang JR, Pugh EJ: Meningococcal infections: Reducing the case fatality rate by giving penicillin before admission to hospital. BMJ 1992; 305:141-143.
11. Scheld WM: Is there a place for carbapenem in the therapy for meningitis? Curr Opin Infect Dis 1994; 7(suppl 1):S33-S37.
12. van de Laar MJ, van Duynhoven YT, Dessens M, van Santen M, van Klingeren B: Surveillance of antibiotic resistance in Neisseria gonorrhoeae in The Netherlands, 1977-95. Genitourin Med 1997;73:510-517.
13. Adegbola RA, Sabally S, Corrah T, West B, Mabey D: Increasing prevalence of penicillinase-producing Neisseria gonorrhoeae and the emergence of high-level, plasmid-mediated tetracycline resistance among gonococcal isolates in The Gambia. Trop Med Int Health 1997;2:428-432.
14. van de Beek D, Hensen EF, Spanjaard L, de Gans J, Enting RH, Dankert J: Meropenem susceptibility of Neisseria meningitidis and Streptococcus pneumoniae from meningitis patients in The Netherlands. J Antimicrob Chemother 1997;40:895-897.
15. Drusano GL: Closing remarks. Curr Opin Infect Dis 1994;7(suppl 1): S44-S45.